<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Natural killer (NK) cells can alter the outcome of hematopoietic cell transplantation (HCT) if donor alloreactivity targets the recipient </plain></SENT>
<SENT sid="1" pm="."><plain>Since most NK cells express inhibitory killer-immunoglobulin receptors (KIRs), we hypothesized that the susceptibility of recipient cells to donor NK cell-mediated lysis is genetically predetermined by the absence of known KIR ligands </plain></SENT>
<SENT sid="2" pm="."><plain>We analyzed data from 2062 patients undergoing unrelated donor HCT for <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>; n = 556), <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>; n = 1224), and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>; n = 282) </plain></SENT>
<SENT sid="3" pm="."><plain>Missing 1 or more KIR ligands versus the presence of <z:hpo ids='HP_0000001'>all</z:hpo> ligands protected against relapse in patients with early myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (relative risk [RR] = 0.54; n = 536, 95% confidence interval [CI] 0.30-0.95, P = .03) </plain></SENT>
<SENT sid="4" pm="."><plain>In the subset of <z:mp ids='MP_0005481'>CML</z:mp> patients that received a transplant beyond 1 year from diagnosis (n = 479), missing a KIR ligand independently predicted a greater risk of developing grade 3-4 <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> (GVHD; RR = 1.58, 95% CI 1.13-2.22; P = .008) </plain></SENT>
<SENT sid="5" pm="."><plain>These data support a genetically determined role for NK cells following unrelated HCT in myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
</text></document>